1 Introduction to Research & Analysis Reports
1.1 Glioma Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glioma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Glioma Treatment Overall Market Size
2.1 Global Glioma Treatment Market Size: 2022 VS 2029
2.2 Global Glioma Treatment Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Glioma Treatment Sales: 2018-2029
3 Company Landscape
3.1 Top Glioma Treatment Players in Global Market
3.2 Top Global Glioma Treatment Companies Ranked by Revenue
3.3 Global Glioma Treatment Revenue by Companies
3.4 Global Glioma Treatment Sales by Companies
3.5 Global Glioma Treatment Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Glioma Treatment Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Glioma Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Glioma Treatment Players in Global Market
3.8.1 List of Global Tier 1 Glioma Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Glioma Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Glioma Treatment Market Size Markets, 2022 & 2029
4.1.2 ChemOthersapy
4.1.3 Drugs
4.2 By Type – Global Glioma Treatment Revenue & Forecasts
4.2.1 By Type – Global Glioma Treatment Revenue, 2018-2023
4.2.2 By Type – Global Glioma Treatment Revenue, 2024-2029
4.2.3 By Type – Global Glioma Treatment Revenue Market Share, 2018-2029
4.3 By Type – Global Glioma Treatment Sales & Forecasts
4.3.1 By Type – Global Glioma Treatment Sales, 2018-2023
4.3.2 By Type – Global Glioma Treatment Sales, 2024-2029
4.3.3 By Type – Global Glioma Treatment Sales Market Share, 2018-2029
4.4 By Type – Global Glioma Treatment Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Glioma Treatment Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Cancer Research Organizations
5.1.4 Diagnostic Centers
5.1.5 Others
5.2 By Application – Global Glioma Treatment Revenue & Forecasts
5.2.1 By Application – Global Glioma Treatment Revenue, 2018-2023
5.2.2 By Application – Global Glioma Treatment Revenue, 2024-2029
5.2.3 By Application – Global Glioma Treatment Revenue Market Share, 2018-2029
5.3 By Application – Global Glioma Treatment Sales & Forecasts
5.3.1 By Application – Global Glioma Treatment Sales, 2018-2023
5.3.2 By Application – Global Glioma Treatment Sales, 2024-2029
5.3.3 By Application – Global Glioma Treatment Sales Market Share, 2018-2029
5.4 By Application – Global Glioma Treatment Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Glioma Treatment Market Size, 2022 & 2029
6.2 By Region – Global Glioma Treatment Revenue & Forecasts
6.2.1 By Region – Global Glioma Treatment Revenue, 2018-2023
6.2.2 By Region – Global Glioma Treatment Revenue, 2024-2029
6.2.3 By Region – Global Glioma Treatment Revenue Market Share, 2018-2029
6.3 By Region – Global Glioma Treatment Sales & Forecasts
6.3.1 By Region – Global Glioma Treatment Sales, 2018-2023
6.3.2 By Region – Global Glioma Treatment Sales, 2024-2029
6.3.3 By Region – Global Glioma Treatment Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Glioma Treatment Revenue, 2018-2029
6.4.2 By Country – North America Glioma Treatment Sales, 2018-2029
6.4.3 US Glioma Treatment Market Size, 2018-2029
6.4.4 Canada Glioma Treatment Market Size, 2018-2029
6.4.5 Mexico Glioma Treatment Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Glioma Treatment Revenue, 2018-2029
6.5.2 By Country – Europe Glioma Treatment Sales, 2018-2029
6.5.3 Germany Glioma Treatment Market Size, 2018-2029
6.5.4 France Glioma Treatment Market Size, 2018-2029
6.5.5 U.K. Glioma Treatment Market Size, 2018-2029
6.5.6 Italy Glioma Treatment Market Size, 2018-2029
6.5.7 Russia Glioma Treatment Market Size, 2018-2029
6.5.8 Nordic Countries Glioma Treatment Market Size, 2018-2029
6.5.9 Benelux Glioma Treatment Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Glioma Treatment Revenue, 2018-2029
6.6.2 By Region – Asia Glioma Treatment Sales, 2018-2029
6.6.3 China Glioma Treatment Market Size, 2018-2029
6.6.4 Japan Glioma Treatment Market Size, 2018-2029
6.6.5 South Korea Glioma Treatment Market Size, 2018-2029
6.6.6 Southeast Asia Glioma Treatment Market Size, 2018-2029
6.6.7 India Glioma Treatment Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Glioma Treatment Revenue, 2018-2029
6.7.2 By Country – South America Glioma Treatment Sales, 2018-2029
6.7.3 Brazil Glioma Treatment Market Size, 2018-2029
6.7.4 Argentina Glioma Treatment Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Glioma Treatment Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Glioma Treatment Sales, 2018-2029
6.8.3 Turkey Glioma Treatment Market Size, 2018-2029
6.8.4 Israel Glioma Treatment Market Size, 2018-2029
6.8.5 Saudi Arabia Glioma Treatment Market Size, 2018-2029
6.8.6 UAE Glioma Treatment Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sun Pharmaceutical
7.1.1 Sun Pharmaceutical Company Summary
7.1.2 Sun Pharmaceutical Business Overview
7.1.3 Sun Pharmaceutical Glioma Treatment Major Product Offerings
7.1.4 Sun Pharmaceutical Glioma Treatment Sales and Revenue in Global (2018-2023)
7.1.5 Sun Pharmaceutical Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Glioma Treatment Major Product Offerings
7.2.4 Amgen Glioma Treatment Sales and Revenue in Global (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Teva Pharmaceutical
7.3.1 Teva Pharmaceutical Company Summary
7.3.2 Teva Pharmaceutical Business Overview
7.3.3 Teva Pharmaceutical Glioma Treatment Major Product Offerings
7.3.4 Teva Pharmaceutical Glioma Treatment Sales and Revenue in Global (2018-2023)
7.3.5 Teva Pharmaceutical Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Glioma Treatment Major Product Offerings
7.4.4 Bristol-Myers Squibb Glioma Treatment Sales and Revenue in Global (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Glioma Treatment Major Product Offerings
7.5.4 Pfizer Glioma Treatment Sales and Revenue in Global (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Glioma Treatment Major Product Offerings
7.6.4 Merck Glioma Treatment Sales and Revenue in Global (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 Eli Lilly
7.7.1 Eli Lilly Company Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Glioma Treatment Major Product Offerings
7.7.4 Eli Lilly Glioma Treatment Sales and Revenue in Global (2018-2023)
7.7.5 Eli Lilly Key News & Latest Developments
7.8 F. Hoffmann-La Roche Ltd
7.8.1 F. Hoffmann-La Roche Ltd Company Summary
7.8.2 F. Hoffmann-La Roche Ltd Business Overview
7.8.3 F. Hoffmann-La Roche Ltd Glioma Treatment Major Product Offerings
7.8.4 F. Hoffmann-La Roche Ltd Glioma Treatment Sales and Revenue in Global (2018-2023)
7.8.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.9 AbbVie
7.9.1 AbbVie Company Summary
7.9.2 AbbVie Business Overview
7.9.3 AbbVie Glioma Treatment Major Product Offerings
7.9.4 AbbVie Glioma Treatment Sales and Revenue in Global (2018-2023)
7.9.5 AbbVie Key News & Latest Developments
7.10 Genentech
7.10.1 Genentech Company Summary
7.10.2 Genentech Business Overview
7.10.3 Genentech Glioma Treatment Major Product Offerings
7.10.4 Genentech Glioma Treatment Sales and Revenue in Global (2018-2023)
7.10.5 Genentech Key News & Latest Developments
7.11 BioMimetix
7.11.1 BioMimetix Company Summary
7.11.2 BioMimetix Glioma Treatment Business Overview
7.11.3 BioMimetix Glioma Treatment Major Product Offerings
7.11.4 BioMimetix Glioma Treatment Sales and Revenue in Global (2018-2023)
7.11.5 BioMimetix Key News & Latest Developments
7.12 Cipla
7.12.1 Cipla Company Summary
7.12.2 Cipla Glioma Treatment Business Overview
7.12.3 Cipla Glioma Treatment Major Product Offerings
7.12.4 Cipla Glioma Treatment Sales and Revenue in Global (2018-2023)
7.12.5 Cipla Key News & Latest Developments
7.13 Sigma-Aldrich
7.13.1 Sigma-Aldrich Company Summary
7.13.2 Sigma-Aldrich Glioma Treatment Business Overview
7.13.3 Sigma-Aldrich Glioma Treatment Major Product Offerings
7.13.4 Sigma-Aldrich Glioma Treatment Sales and Revenue in Global (2018-2023)
7.13.5 Sigma-Aldrich Key News & Latest Developments
7.14 Panacea Biotec
7.14.1 Panacea Biotec Company Summary
7.14.2 Panacea Biotec Business Overview
7.14.3 Panacea Biotec Glioma Treatment Major Product Offerings
7.14.4 Panacea Biotec Glioma Treatment Sales and Revenue in Global (2018-2023)
7.14.5 Panacea Biotec Key News & Latest Developments
7.15 Zydus Cadila
7.15.1 Zydus Cadila Company Summary
7.15.2 Zydus Cadila Business Overview
7.15.3 Zydus Cadila Glioma Treatment Major Product Offerings
7.15.4 Zydus Cadila Glioma Treatment Sales and Revenue in Global (2018-2023)
7.15.5 Zydus Cadila Key News & Latest Developments
7.16 Takeda Pharmaceuticals
7.16.1 Takeda Pharmaceuticals Company Summary
7.16.2 Takeda Pharmaceuticals Business Overview
7.16.3 Takeda Pharmaceuticals Glioma Treatment Major Product Offerings
7.16.4 Takeda Pharmaceuticals Glioma Treatment Sales and Revenue in Global (2018-2023)
7.16.5 Takeda Pharmaceuticals Key News & Latest Developments
7.17 Boston Biomedical
7.17.1 Boston Biomedical Company Summary
7.17.2 Boston Biomedical Business Overview
7.17.3 Boston Biomedical Glioma Treatment Major Product Offerings
7.17.4 Boston Biomedical Glioma Treatment Sales and Revenue in Global (2018-2023)
7.17.5 Boston Biomedical Key News & Latest Developments
7.18 Ziopharm Oncology
7.18.1 Ziopharm Oncology Company Summary
7.18.2 Ziopharm Oncology Business Overview
7.18.3 Ziopharm Oncology Glioma Treatment Major Product Offerings
7.18.4 Ziopharm Oncology Glioma Treatment Sales and Revenue in Global (2018-2023)
7.18.5 Ziopharm Oncology Key News & Latest Developments
7.19 Celldex Therapeutics
7.19.1 Celldex Therapeutics Company Summary
7.19.2 Celldex Therapeutics Business Overview
7.19.3 Celldex Therapeutics Glioma Treatment Major Product Offerings
7.19.4 Celldex Therapeutics Glioma Treatment Sales and Revenue in Global (2018-2023)
7.19.5 Celldex Therapeutics Key News & Latest Developments
7.20 BERG
7.20.1 BERG Company Summary
7.20.2 BERG Business Overview
7.20.3 BERG Glioma Treatment Major Product Offerings
7.20.4 BERG Glioma Treatment Sales and Revenue in Global (2018-2023)
7.20.5 BERG Key News & Latest Developments
7.21 Oncorus
7.21.1 Oncorus Company Summary
7.21.2 Oncorus Business Overview
7.21.3 Oncorus Glioma Treatment Major Product Offerings
7.21.4 Oncorus Glioma Treatment Sales and Revenue in Global (2018-2023)
7.21.5 Oncorus Key News & Latest Developments
7.22 Agenus
7.22.1 Agenus Company Summary
7.22.2 Agenus Business Overview
7.22.3 Agenus Glioma Treatment Major Product Offerings
7.22.4 Agenus Glioma Treatment Sales and Revenue in Global (2018-2023)
7.22.5 Agenus Key News & Latest Developments
7.23 Deciphera Pharmaceuticals
7.23.1 Deciphera Pharmaceuticals Company Summary
7.23.2 Deciphera Pharmaceuticals Business Overview
7.23.3 Deciphera Pharmaceuticals Glioma Treatment Major Product Offerings
7.23.4 Deciphera Pharmaceuticals Glioma Treatment Sales and Revenue in Global (2018-2023)
7.23.5 Deciphera Pharmaceuticals Key News & Latest Developments
7.24 Karyopharm Therapeutics
7.24.1 Karyopharm Therapeutics Company Summary
7.24.2 Karyopharm Therapeutics Business Overview
7.24.3 Karyopharm Therapeutics Glioma Treatment Major Product Offerings
7.24.4 Karyopharm Therapeutics Glioma Treatment Sales and Revenue in Global (2018-2023)
7.24.5 Karyopharm Therapeutics Key News & Latest Developments
8 Global Glioma Treatment Production Capacity, Analysis
8.1 Global Glioma Treatment Production Capacity, 2018-2029
8.2 Glioma Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Glioma Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Glioma Treatment Supply Chain Analysis
10.1 Glioma Treatment Industry Value Chain
10.2 Glioma Treatment Upstream Market
10.3 Glioma Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Glioma Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の神経膠腫治療市場予測2023-2029：化学薬品、医薬品 |
| 【英語タイトル】Glioma Treatment Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5590 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：123 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の神経膠腫治療市場規模と予測を収録しています。・世界の神経膠腫治療市場：売上、2018年-2023年、2024年-2029年 ・世界の神経膠腫治療市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の神経膠腫治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「化学薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 神経膠腫治療のグローバル主要企業は、Sun Pharmaceutical、 Amgen、 Teva Pharmaceutical、 Bristol-Myers Squibb、 Pfizer、 Merck、 Eli Lilly、 F. Hoffmann-La Roche Ltd、 AbbVie、 Genentech、 BioMimetix、 Cipla、 Sigma-Aldrich、 Panacea Biotec、 Zydus Cadila、 Takeda Pharmaceuticals、 Boston Biomedical、 Ziopharm Oncology、 Celldex Therapeutics、 BERG、 Oncorus、 Agenus、 Deciphera Pharmaceuticals、 Karyopharm Therapeuticsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、神経膠腫治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の神経膠腫治療市場：タイプ別、2018年-2023年、2024年-2029年 世界の神経膠腫治療市場：タイプ別市場シェア、2022年 ・化学薬品、医薬品 世界の神経膠腫治療市場：用途別、2018年-2023年、2024年-2029年 世界の神経膠腫治療市場：用途別市場シェア、2022年 ・病院、がん研究機関、診断センター、その他 世界の神経膠腫治療市場：地域・国別、2018年-2023年、2024年-2029年 世界の神経膠腫治療市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における神経膠腫治療のグローバル売上、2018年-2023年 ・主要企業における神経膠腫治療のグローバル売上シェア、2022年 ・主要企業における神経膠腫治療のグローバル販売量、2018年-2023年 ・主要企業における神経膠腫治療のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Sun Pharmaceutical、 Amgen、 Teva Pharmaceutical、 Bristol-Myers Squibb、 Pfizer、 Merck、 Eli Lilly、 F. Hoffmann-La Roche Ltd、 AbbVie、 Genentech、 BioMimetix、 Cipla、 Sigma-Aldrich、 Panacea Biotec、 Zydus Cadila、 Takeda Pharmaceuticals、 Boston Biomedical、 Ziopharm Oncology、 Celldex Therapeutics、 BERG、 Oncorus、 Agenus、 Deciphera Pharmaceuticals、 Karyopharm Therapeutics ************************************************************* ・調査・分析レポートの概要 神経膠腫治療市場の定義 市場セグメント 世界の神経膠腫治療市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の神経膠腫治療市場規模 世界の神経膠腫治療市場規模：2022年 VS 2029年 世界の神経膠腫治療市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの神経膠腫治療の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の神経膠腫治療製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：化学薬品、医薬品 神経膠腫治療のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、がん研究機関、診断センター、その他 神経膠腫治療の用途別グローバル売上・予測 ・地域別市場分析 地域別神経膠腫治療市場規模 2022年と2029年 地域別神経膠腫治療売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Sun Pharmaceutical、 Amgen、 Teva Pharmaceutical、 Bristol-Myers Squibb、 Pfizer、 Merck、 Eli Lilly、 F. Hoffmann-La Roche Ltd、 AbbVie、 Genentech、 BioMimetix、 Cipla、 Sigma-Aldrich、 Panacea Biotec、 Zydus Cadila、 Takeda Pharmaceuticals、 Boston Biomedical、 Ziopharm Oncology、 Celldex Therapeutics、 BERG、 Oncorus、 Agenus、 Deciphera Pharmaceuticals、 Karyopharm Therapeutics ... |
Chemotherapy is usually used in combination with radiation therapy to treat gliomas. The chemotherapy drug used most often to treat gliomas is temozolomide (Temodar), which is taken as a pill. Side effects of chemotherapy depend on the type and dose of drugs you receive.
This report aims to provide a comprehensive presentation of the global market for Glioma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glioma Treatment. This report contains market size and forecasts of Glioma Treatment in global, including the following market information:
Global Glioma Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Glioma Treatment Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Glioma Treatment companies in 2022 (%)
The global Glioma Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
ChemOthersapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Glioma Treatment include Sun Pharmaceutical, Amgen, Teva Pharmaceutical, Bristol-Myers Squibb, Pfizer, Merck, Eli Lilly, F. Hoffmann-La Roche Ltd and AbbVie, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glioma Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glioma Treatment Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glioma Treatment Market Segment Percentages, by Type, 2022 (%)
ChemOthersapy
Drugs
Global Glioma Treatment Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glioma Treatment Market Segment Percentages, by Application, 2022 (%)
Hospitals
Cancer Research Organizations
Diagnostic Centers
Others
Global Glioma Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glioma Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glioma Treatment revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Glioma Treatment revenues share in global market, 2022 (%)
Key companies Glioma Treatment sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Glioma Treatment sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sun Pharmaceutical
Amgen
Teva Pharmaceutical
Bristol-Myers Squibb
Pfizer
Merck
Eli Lilly
F. Hoffmann-La Roche Ltd
AbbVie
Genentech
BioMimetix
Cipla
Sigma-Aldrich
Panacea Biotec
Zydus Cadila
Takeda Pharmaceuticals
Boston Biomedical
Ziopharm Oncology
Celldex Therapeutics
BERG
Oncorus
Agenus
Deciphera Pharmaceuticals
Karyopharm Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Glioma Treatment, market overview.
Chapter 2: Global Glioma Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Glioma Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Glioma Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Glioma Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の神経膠腫治療市場予測2023-2029：化学薬品、医薬品] (コード：MMG23JU5590)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の神経膠腫治療市場予測2023-2029：化学薬品、医薬品]についてメールでお問い合わせ |
